胸腺嘧啶核苷磷酸化酶(TP)重组蛋白
Recombinant Thymidine Phosphorylase (TP)
FOR IN VITRO AND RESEARCH USE ONLY, NOT FOR USE IN CLINICAL DIAGNOSTIC PROCEDURES!
|
Organism species
|
Homo sapiens (Human)
|
|
Product No.
|
KL948Hu01
|
|
Source
|
Prokaryotic expression
|
|
Host
|
E.coli
|
|
Purity
|
> 95%
|
|
UOM
|
50ug
|
|
Predicted Molecular Mass
|
23.5kDa
|
|
Concentration
|
n/a
|
|
Applications
|
SDS-PAGE; WB; ELISA; IP.
|
|
Endotoxin Level
|
<1.0EU per 1µg (determined by the LAL method)
|
|
Residues
|
Glu38~Gln247 with N-terminal His-Tag
|
|
Formulation
|
Supplied as lyophilized form in 20mM Tris, 150mM NaCl, pH8.0, containing 1mM EDTA, 1mM DTT, 0.01% sarcosyl, 5% trehalose, and preservative.
|
胸腺嘧啶核苷磷酸化酶(TP)重组蛋白SEQUENCES
The sequence of the target protein is listed below.
ELI RMKRDGGRLS EADIRGFVAA VVNGSAQGAQ IGAMLMAIRL RGMDLEETSV LTQALAQSGQ QLEWPEAWRQ QLVDKHSTGG VGDKVSLVLA PALAACGCKV PMISGRGLGH TGGTLDKLES IPGFNVIQSP EQMQVLLDQA GCCIVGQSEQ LVPADGILYA ARDVTATVDS LPLITASILS KKLVEGLSAL VVDVKFGGAA VFPNQEQ
胸腺嘧啶核苷磷酸化酶(TP)重组蛋白USAGE
Reconstitute in sterile ddH2O.
胸腺嘧啶核苷磷酸化酶(TP)重组蛋白STORAGE AND STABILITY
Storage: Avoid repeated freeze/thaw cycles. Store at 2-8oC for one month. Aliquot and store at -80oC for 12 months.
Stability Test: The thermal stability is described by the loss rate of the target protein. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37oC for 48h, and no obvious degradation and precipitation were observed. (Referring from China Biological Products Standard, which was calculated by the Arrhenius equation.) The loss of this protein is less than 5% within the expiration date under appropriate storage condition.
胸腺嘧啶核苷磷酸化酶(TP)重组蛋白About the MARKER (complimentary)
Effective Size Range: 10kDa to 70kDa.
Protein bands: 10kDa, 14kDa, 18kDa, 22kDa, 26kDa, 33kDa, 44kDa and 70kDa.
Double intensity bands: The 26kDa, 18kDa, 10kDa bands are at double intensity to make location and size approximation of proteins of interest quick and easy.
Ready-to-use: No need to heat, dilute or add reducing agents before use.
KL093Si01 巨噬细胞炎性蛋白1β(MIP1β)重组蛋白 Recombinant Macrophage Inflammatory Protein 1 Beta (MIP1b) Rhesus monkey (Simian)
KL095Bo01 巨噬细胞炎性蛋白3α(MIP3α)重组蛋白 Recombinant Macrophage Inflammatory Protein 3 Alpha (MIP3a) Bos taurus; Bovine (Cattle)
KL095Ca01 巨噬细胞炎性蛋白3α(MIP3α)重组蛋白 Recombinant Macrophage Inflammatory Protein 3 Alpha (MIP3a) Canis familiaris; Canine (Dog)
KL095Hu01 巨噬细胞炎性蛋白3α(MIP3α)重组蛋白 Recombinant Macrophage Inflammatory Protein 3 Alpha (MIP3a) Homo sapiens (Human)
KL095Mu01 巨噬细胞炎性蛋白3α(MIP3α)重组蛋白 Recombinant Macrophage Inflammatory Protein 3 Alpha (MIP3a) Mus musculus (Mouse)
KL095Po01 巨噬细胞炎性蛋白3α(MIP3α)重组蛋白 Recombinant Macrophage Inflammatory Protein 3 Alpha (MIP3a) Sus scrofa; Porcine (Pig)
KL095Ra01 巨噬细胞炎性蛋白3α(MIP3α)重组蛋白 Recombinant Macrophage Inflammatory Protein 3 Alpha (MIP3a) Rattus norvegicus (Rat)
KL096Bo01 巨噬细胞炎性蛋白3β(MIP3β)重组蛋白 Recombinant Macrophage Inflammatory Protein 3 Beta (MIP3b) Bos taurus; Bovine (Cattle)
KL096Ca01 巨噬细胞炎性蛋白3β(MIP3β)重组蛋白 Recombinant Macrophage Inflammatory Protein 3 Beta (MIP3b) Canis familiaris; Canine (Dog)
